Multifunctional nanoparticles for enhanced sonodynamic–chemodynamic immunotherapy with glutathione depletion

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Moghaddam FD, Heidari G, Zare EN et al. Carbohydrate polymer-based nanocomposites for breast cancer treatment. Carbohydr. Polym. 304, 120510 (2023).
  Medline CASGoogle Scholar
• 2. Moammeri A, Abbaspour K, Zafarian A et al. pH-responsive, adorned nanoniosomes for codelivery of cisplatin and epirubicin: synergistic treatment of breast cancer. ACS Appl. Bio Mater. 5(2), 675–690 (2022).
  Medline CASGoogle Scholar
• 3. Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet 397(10286), 1750–1769 (2021). • Clarified the current complexity and limitations of breast cancer radiotherapy.
  Medline CASGoogle Scholar
• 4. Waks AG, Winer EP. Breast cancer treatment: a review. JAMA 321(3), 288–300 (2019).
  Medline CASGoogle Scholar
• 5. Makvandi P, Chen M, Sartorius R et al. Endocytosis of abiotic nanomaterials and nanobiovectors: inhibition of membrane trafficking. Nano Today 40, 101279 (2021).
  Medline CASGoogle Scholar
• 6. Zhu Y, Yu X, Thamphiwatana SD, Zheng Y, Pang Z. Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy. Acta Pharm. Sin. B 10(11), 2054–2074 (2020). • Review of existing and potential approaches for immunosuppressive cell modulation inside the immunosuppressive tumor immune microenvironment, reflecting the robust immunotherapeutic responses of nanotechnology-related strategies in modulating the immunosuppressive cells within the tumor immune microenvironment.
  Medline CASGoogle Scholar
• 7. Peng S, Ouyang B, Men Y et al. Biodegradable zwitterionic polymer membrane coating endowing nanoparticles with ultra-long circulation and enhanced tumor photothermal therapy. Biomaterials 231, 119680 (2020).
  Medline CASGoogle Scholar
• 8. Gonzales J, Nair RK, Madsen SJ, Krasieva T, Hirschberg H. Focused ultrasound-mediated sonochemical internalization: an alternative to light-based therapies. J. Biomed. Opt. 21(7), 78002 (2016).
  MedlineGoogle Scholar
• 9. Zhang H, Chen J, Zhu X et al. Ultrasound induced phase-transition and invisible nanobomb for imaging-guided tumor sonodynamic therapy. J. Mater. Chem. B 6(38), 6108–6121 (2018).
  Medline CASGoogle Scholar
• 10. Zhao H, Zhao B, Li L et al. Biomimetic decoy inhibits tumor growth and lung metastasis by reversing the drawbacks of sonodynamic therapy. Adv. Healthc. Mater. 9(1), e1901335 (2020).
  Medline CASGoogle Scholar
• 11. Zhu P, Chen Y, Shi J. Nanoenzyme-augmented cancer sonodynamic therapy by catalytic tumor oxygenation. ACS Nano 12(4), 3780–3795 (2018). • Used MnOx to convert the tumor-overexpressed H2O2 molecules into oxygen, enhancing the tumor oxygen level and subsequently optimizing the low efficacy of the sonosensitizer in the hypoxic tumor microenvironment.
  Medline CASGoogle Scholar
• 12. Zhang C, Xin L, Li J et al. Metal–organic framework (MOF)-based ultrasound-responsive dual-sonosensitizer nanoplatform for hypoxic cancer therapy. Adv. Healthc. Mater. 11(2), e2101946 (2022).
  Medline CASGoogle Scholar
• 13. Ma B, Wang S, Liu F et al. Self-assembled copper–amino acid nanoparticles for in situ glutathione ‘AND’ H₂O₂ sequentially triggered chemodynamic therapy. J. Am. Chem. Soc. 141(2), 849–857 (2019). •• Self-assembled copper–amino acid mercaptide nanoparticles exhibited relatively high cytotoxicity to cancer cells without causing obvious systemic toxicity via inducing glutathione depletion and a Fenton-like reaction, which provided a reference for our design.
  Medline CASGoogle Scholar
• 14. Huo M, Wang L, Chen Y, Shi J. Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat. Commun. 8(1), 357 (2017). • Delivery of ultrasmall Fe3O4 nanoparticles into tumor sites to catalyze Fenton-like reaction and generate highly toxic hydroxyl radicals.
  MedlineGoogle Scholar
• 15. Tang Z, Zhang H, Liu Y et al. Antiferromagnetic pyrite as the tumor microenvironment-mediated nanoplatform for self-enhanced tumor imaging and therapy. Adv. Mater. 29(47), 1701683 (2017). • Pyrite led to surface oxidation and generated hydroxyl radicals to kill tumor cells through the activation of excessive peroxide in the tumor microenvironment.
  Google Scholar
• 16. Lin LS, Song J, Song L et al. Simultaneous Fenton-like ion delivery and glutathione depletion by MnO₂-based nanoagent to enhance chemodynamic therapy. Angew. Chem. Int. Ed. Engl. 57(18), 4902–4906 (2018).
  Medline CASGoogle Scholar
• 17. Xu C, Yuan Z, Kohler N, Kim J, Chung MA, Sun S. FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition. J. Am. Chem. Soc. 131(42), 15346–15351 (2009). • FePt nanoparticles show the controlled release of Fe, which catalyzes H2O2 decomposition into reactive oxygen species within cells.
  Medline CASGoogle Scholar
• 18. Jiao L, Xu Z, Du W, Li H, Yin M. Fast preparation of polydopamine nanoparticles catalyzed by Fe²⁺/H₂O₂ for visible sensitive smartphone-enabled cytosensing. ACS Appl. Mater. Interfaces 9(34), 28339–28345 (2017).
  Medline CASGoogle Scholar
• 19. Bai J, Jia X, Zhen W, Cheng W, Jiang X. A facile ion-doping strategy to regulate tumor microenvironments for enhanced multimodal tumor theranostics. J. Am. Chem. Soc. 140(1), 106–109 (2018).
  Medline CASGoogle Scholar
• 20. Pegis ML, Wise CF, Martin DJ, Mayer JM. Oxygen reduction by homogeneous molecular catalysts and electrocatalysts. Chem. Rev. 118(5), 2340–2391 (2018). • Reported that the released Fe2+ with catalase-like activity can decompose H2O2 into O2, providing hydroxyl radicals to kill tumor cells.
  Medline CASGoogle Scholar
• 21. Zhao H, Wang Y, Wang Y, Cao T, Zhao G. Electro-Fenton oxidation of pesticides with a novel Fe₃O₄@Fe₂O₃/activated carbon aerogel cathode: high activity, wide pH range and catalytic mechanism. Appl. Catal. B 125, 120–127 (2012).
  CASGoogle Scholar
• 22. Masomboon N, Ratanatamskul C, Lu MC. Chemical oxidation of 2,6-dimethylaniline in the Fenton process. Environ. Sci. Technol. 43(22), 8629–8634 (2009).
  Medline CASGoogle Scholar
• 23. Brillas E, Baños MA, Camps S et al. Catalytic effect of Fe²⁺, Cu²⁺ and UVA light on the electrochemical degradation of nitrobenzene using an oxygen-diffusion cathode. New J. Chem. 28(2), 314–322 (2004).
  CASGoogle Scholar
• 24. Lee BK. Enhanced formation of sulfate radicals by metal-doped BiFeO₃ under visible light for improving photo-Fenton catalytic degradation of 2-chlorophenol. Chem. Eng. J. 313, 1258–1268 (2017).
  Google Scholar
• 25. Anandan S, Miyauchi M. Ce-doped ZnO (Ce_(x)Zn_(1-x)O) becomes an efficient visible-light-sensitive photocatalyst by co-catalyst (Cu²⁺) grafting. Phys. Chem. Chem. Phys. 13(33), 14937–14945 (2011).
  Medline CASGoogle Scholar
• 26. Lu J, Jiang Z, Ren J et al. One-Pot synthesis of multifunctional carbon-based nanoparticle-supported dispersed Cu²⁺ disrupts redox homeostasis to enhance CDT. Angew. Chem. Int. Ed. Engl. 61(4), e202114373 (2022).
  Medline CASGoogle Scholar
• 27. Zhou Z, Wu H, Yang R et al. GSH depletion liposome adjuvant for augmenting the photothermal immunotherapy of breast cancer. Sci. Adv. 6(36), eabc4373 (2020).
  Medline CASGoogle Scholar
• 28. Ren H, Yong J, Yang Q et al. Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy. Acta Pharm. Sin. B 11(10), 3244–3261 (2021).
  Medline CASGoogle Scholar
• 29. Su X, Cao Y, Liu Y et al. Localized disruption of redox homeostasis boosting ferroptosis of tumor by hydrogel delivery system. Mater. Today Bio 12, 100154 (2021).
  Medline CASGoogle Scholar
• 30. Feng Z, Chen G, Zhong M et al. An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway. Biomaterials 302, 122333 (2023).
  Medline CASGoogle Scholar
• 31. Wang HX, Zuo ZQ, Du JZ et al. Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines. Nano Today 11(2), 133–144 (2016).
  CASGoogle Scholar
• 32. Han ZY, Chen QW, Zheng DW et al. Inhalable capsular polysaccharide-camouflaged gallium–polyphenol nanoparticles enhance lung cancer chemotherapy by depleting local lung microbiota. Adv. Mater. 35(38), e2302551 (2023).
  Medline CASGoogle Scholar
• 33. Ma ZJ, Lu L, Yang JJ et al. Lariciresinol induces apoptosis in HepG2 cells via mitochondrial-mediated apoptosis pathway. Eur. J. Pharmacol. 821, 1–10 (2018).
  Medline CASGoogle Scholar
• 34. Gharbaran R, Shi C, Onwumere O, Redenti S. Plumbagin induces cytotoxicity via loss of mitochondrial membrane potential and caspase activation in metastatic retinoblastoma. Anticancer Res. 41(10), 4725–4732 (2021).
  Medline CASGoogle Scholar
• 35. Chen Q, Li Q, Liang Y et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharm. Sin. B 12(2), 907–923 (2022).
  MedlineGoogle Scholar
• 36. Yang J, Xie R, Feng L et al. Hyperthermia and controllable free radical coenhanced synergistic therapy in hypoxia enabled by near-infrared-II light irradiation. ACS Nano 13(11), 13144–13160 (2019).
  Medline CASGoogle Scholar
• 37. Tang C, Li H, Sha M et al. A tumor microenvironment responsive titanium-based nanosonosensitizer for combination sonodynamic-immunotherapy with calcium ion overload. Chem. Eng. J. 475, 146054 (2023).
  CASGoogle Scholar
• 38. Ye J, Fu Q, Liu L et al. Ultrasound-propelled Janus Au NR-mSiO₂ nanomotor for NIR-II photoacoustic imaging guided sonodynamic-gas therapy of large tumors. Sci. China Chem. 64(12), 2218–2229 (2021).
  CASGoogle Scholar
• 39. Xiong Y, Xiao C, Li Z, Yang X. Engineering nanomedicine for glutathione depletion-augmented cancer therapy. Chem. Soc. Rev. 50(10), 6013–6041 (2021).
  Medline CASGoogle Scholar
• 40. Zhang Q, Hresko ME, Picton LK et al. A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia. Sci. Transl. Med. 13(625), eabg6986 (2021).
  Medline CASGoogle Scholar
• 41. Roșu MC, Mihnea PD, Ardelean A, Moldovan SD, Popețiu RO, Totolici BD. Clinical significance of tumor necrosis factor-alpha and carcinoembryonic antigen in gastric cancer. J. Med. Life. 15(1), 4–6 (2022).
  MedlineGoogle Scholar
• 42. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120(5), 649–661 (2005).
  Medline CASGoogle Scholar
• 43. Cervera-Carrascon V, Siurala M, Santos JM et al. TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade. Oncoimmunology 7(5), e1412902 (2018).
  Medline CASGoogle Scholar